Rupinder Kaur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Rupinder Kaur has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Gregory A. Graf
Saha Cardiovascular Research Center, College of Medicine, University of Kentucky, Lexington, KY 40508, USA; Department of Physiology, College of Medicine, University of Kentucky, Lexington, KY 40508, USA; Barnstable Brown Diabetes Center, UK Healthcare, Lexington, KY 40508, USA
3 shared publications Ryan E. Temel
Department of Physiology, College of Medicine, University of Kentucky; Saha Cardiovascular Research Center
2 shared publicationsAiling Ji
Internal Medicine, College of Medicine (A.J., D.R.v.d.W.), University of Kentucky, Lexington
1 shared publicationAiman A. Zein
Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON K1H 8M5, Canada
1 shared publicationBradley H Thompson
Department of Pharmaceutical Sciences, College of Pharmacy
1 shared publication- Chirag Pasricha
Chitkara College of Pharmacy, Chitkara University, Punjab, India
1 shared publication
Latest Publications
- 19 July 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 139, 112709
Pathological insights into activin A: Molecular underpinnings and therapeutic prospects in various diseases
- 19 July 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 139, 112709
Pathological insights into activin A: Molecular underpinnings and therapeutic prospects in various diseases
- 1 February 2020
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 76, 108263
Stigmasterol stimulates transintestinal cholesterol excretion independent of liver X receptor activation in the small intestine
- 1 February 2020
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 76, 108263
Stigmasterol stimulates transintestinal cholesterol excretion independent of liver X receptor activation in the small intestine
- Open Access
- 18 October 2019
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 47 (5) , 1259-1268
ABCG5/G8: a structural view to pathophysiology of the hepatobiliary cholesterol secretion
The ABCG5/G8 heterodimer is the primary neutral sterol transporter in hepatobiliary and transintestinal cholesterol excretion. Inactivating mutations on either the ABCG5 or ABCG8 subunit cause Sitosterolemia, a rare genetic disorder. In 2016, a crystal structure of human ABCG5/G8 in an apo state showed the first structural information on ATP-binding cassette (ABC) sterol transporters and revealed several structural features that were observed for the first time. Over the past decade, several missense variants of ABCG5/G8 have been associated with non-Sitosterolemia lipid phenotypes. In this review, we summarize recent pathophysiological and structural findings of ABCG5/G8, interpret the structure-function relationship in disease-causing variants and describe the available evidence that allows us to build a mechanistic view of ABCG5/G8-mediated sterol transport.
- 18 October 2019
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 47 (5) , 1259-1268
Open AccessABCG5/G8: a structural view to pathophysiology of the hepatobiliary cholesterol secretion
The ABCG5/G8 heterodimer is the primary neutral sterol transporter in hepatobiliary and transintestinal cholesterol excretion. Inactivating mutations on either the ABCG5 or ABCG8 subunit cause Sitosterolemia, a rare genetic disorder. In 2016, a crystal structure of human ABCG5/G8 in an apo state showed the first structural information on ATP-binding cassette (ABC) sterol transporters and revealed several structural features that were observed for the first time. Over the past decade, several missense variants of ABCG5/G8 have been associated with non-Sitosterolemia lipid phenotypes. In this review, we summarize recent pathophysiological and structural findings of ABCG5/G8, interpret the structure-function relationship in disease-causing variants and describe the available evidence that allows us to build a mechanistic view of ABCG5/G8-mediated sterol transport.
- 1 October 2019
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 39 (10) , 1986-1995
Simultaneous Determination of Biliary and Intestinal Cholesterol Secretion Reveals That CETP (Cholesteryl Ester Transfer Protein) Alters Elimination Route in Mice
Objective: Determine the impact of CETP (cholesteryl ester transfer protein) on the route of cholesterol elimination in mice. Approach and Results: We adapted our protocol for biliary cholesterol secretion with published methods for measuring transintestinal cholesterol elimination. Bile was diverted and biliary lipid secretion maintained by infusion of bile acid. The proximal small bowel was perfused with bile acid micelles. In high-fat, high-cholesterol–fed mice, the presence of a CETP transgene increased biliary cholesterol secretion at the expense of transintestinal cholesterol elimination. The increase in biliary cholesterol secretion was not associated with increases in hepatic SR-BI (scavenger receptor BI) or ABCG5 (ATP-binding cassette G5) ABCG8. The decline in intestinal cholesterol secretion was associated with an increase in intestinal Niemann-Pick disease, type C1, gene-like 1 mRNA. Finally, we followed the delivery of HDL (high-density lipoprotein) or LDL (low-density lipoprotein) cholesteryl esters (CE) from plasma to bile and intestinal perfusates. HDL-CE favored the biliary pathway. Following high-fat feeding, the presence of CETP directed HDL-CE away from the bile and towards the intestine. The presence of CETP increased LDL-CE delivery to bile, whereas the appearance of LDL-CE in intestinal perfusate was near the lower limit of detection. Conclusions: Biliary and intestinal cholesterol secretion can be simultaneously measured in mice and used as a model to examine factors that alter cholesterol elimination. Plasma factors, such as CETP, alter the route of cholesterol elimination from the body. Intestinal and biliary cholesterol secretion rates are independent of transhepatic or transintestinal delivery of HDL-CE, whereas LDL-CE was eliminated almost exclusively in the hepatobiliary pathway.
- 1 October 2019
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 39 (10) , 1986-1995
Simultaneous Determination of Biliary and Intestinal Cholesterol Secretion Reveals That CETP (Cholesteryl Ester Transfer Protein) Alters Elimination Route in Mice
Objective: Determine the impact of CETP (cholesteryl ester transfer protein) on the route of cholesterol elimination in mice. Approach and Results: We adapted our protocol for biliary cholesterol secretion with published methods for measuring transintestinal cholesterol elimination. Bile was diverted and biliary lipid secretion maintained by infusion of bile acid. The proximal small bowel was perfused with bile acid micelles. In high-fat, high-cholesterol–fed mice, the presence of a CETP transgene increased biliary cholesterol secretion at the expense of transintestinal cholesterol elimination. The increase in biliary cholesterol secretion was not associated with increases in hepatic SR-BI (scavenger receptor BI) or ABCG5 (ATP-binding cassette G5) ABCG8. The decline in intestinal cholesterol secretion was associated with an increase in intestinal Niemann-Pick disease, type C1, gene-like 1 mRNA. Finally, we followed the delivery of HDL (high-density lipoprotein) or LDL (low-density lipoprotein) cholesteryl esters (CE) from plasma to bile and intestinal perfusates. HDL-CE favored the biliary pathway. Following high-fat feeding, the presence of CETP directed HDL-CE away from the bile and towards the intestine. The presence of CETP increased LDL-CE delivery to bile, whereas the appearance of LDL-CE in intestinal perfusate was near the lower limit of detection. Conclusions: Biliary and intestinal cholesterol secretion can be simultaneously measured in mice and used as a model to examine factors that alter cholesterol elimination. Plasma factors, such as CETP, alter the route of cholesterol elimination from the body. Intestinal and biliary cholesterol secretion rates are independent of transhepatic or transintestinal delivery of HDL-CE, whereas LDL-CE was eliminated almost exclusively in the hepatobiliary pathway.
- 25 October 2016
- Published by Springer Nature
- p. 1-16
Lipid-Coated Gold Nanoparticles as Probes for Membrane Binding
- 25 October 2016
- Published by Springer Nature
- p. 1-16
Lipid-Coated Gold Nanoparticles as Probes for Membrane Binding